. 2018 Jul;39(7):573–578. [Article in Chinese] doi: 10.3760/cma.j.issn.0253-2727.2018.07.009
2018年版权归中华医学会所有
Copyright © 2018 by Chinese Medical Association
This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal.
图2. 首剂利妥昔单抗治疗后第14、30、60天预测疗效的ROC曲线.
